Advisory Commission on Childhood Vaccines, 52314 [2017-24493]

Download as PDF 52314 Federal Register / Vol. 82, No. 217 / Monday, November 13, 2017 / Notices or other forms of information technology to minimize the information collection burden. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2017–24495 Filed 11–9–17; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act (FACA), notice is hereby given that a meeting is scheduled for the Advisory Commission on Childhood Vaccines (ACCV). This meeting will be open to the public. Information about the ACCV and the agenda for this meeting can be obtained by accessing the following Web site: http://www.hrsa.gov/ advisorycommittees/childhoodvaccines/ index.html. SUMMARY: The meeting will be held on December 8, 2017, at 9:00 a.m. ET. ADDRESSES: The address for the meeting is 5600 Fishers Lane, Rockville, MD, Conference Room 5N54. The public can join the meeting by: 1. (In Person) Persons interested in attending the meeting in person are encouraged to submit a written notification to: Annie Herzog, Division of Injury Compensation Programs (DICP), Healthcare Systems Bureau (HSB), HRSA, Room 08N146B, 5600 Fishers Lane, Rockville, Maryland 20857 or email: aherzog@hrsa.gov. Since this meeting is to be held in a federal government building, attendees will need to go through a security check to enter the building and participate in the meeting. Written notification is encouraged so that a list of attendees can be provided to make entry through security quicker. Persons may attend in person without providing written notification, but their entry into the building may be delayed due to security checks and the requirement to be escorted to the meeting by a federal government employee. To request an escort to the meeting after entering the building, call Amber Johnson at (301) 443–0129. asabaliauskas on DSKBBXCHB2PROD with NOTICES DATES: VerDate Sep<11>2014 18:38 Nov 09, 2017 Jkt 244001 2. (Audio Portion) Calling the conference phone number 1–800–369– 1833 and providing the following information: Leader Name: Dr. Narayan Nair. Password: 6706374. 3. (Visual Portion) Connecting to the ACCV Adobe Connect Pro Meeting using the following URL: https:// hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work directly, and enter as a guest). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https:// hrsa.connectsolutions.com/common/ help/en/support/meeting_test.htm and get a quick overview by following URL: http://www.adobe.com/go/connectpro_ overview. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACCV should contact Annie Herzog, Program Analyst, DICP, HRSA in one of three ways: (1) Send a request to the following address: Annie Herzog, Program Analyst, DICP, HSB, HRSA, 5600 Fishers Lane, 08N146B, Rockville, Maryland 20857; (2) call (301) 443–6593; or (3) send an email to aherzog@hrsa.gov. The ACCV will meet on Friday, December 8, 2017, beginning at 9:00 a.m. ET in the 5600 Fishers Lane Building, Conference Room 5N54, Rockville, Maryland 20857; however, meeting times and locations could change. For the latest information regarding meeting start time and location, please check the ACCV Web site: http://www.hrsa.gov/ advisorycommittees/childhoodvaccines/ index.html. SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of the Public Health Service Act (the Act) (42 U.S.C. 300aa–19), as enacted by Public Law (Pub. L.) 99–660, and as subsequently amended, and advises the Secretary of HHS (the Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). Other activities of the ACCV include: Recommending changes to the Vaccine Injury Table at its own initiative or as the result of the filing of a petition; advising the Secretary in implementing section 2127 of the Act regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions; surveying federal, state, and local programs and activities related to gathering information on injuries associated with PO 00000 Frm 00051 Fmt 4703 Sfmt 9990 the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b) of the Act; advising the Secretary on the methods of obtaining, compiling, publishing, and using credible data related to the frequency and severity of adverse reactions associated with childhood vaccines; consulting on the development or revision of Vaccine Information Statements; and recommending to the Director of the National Vaccine Program research related to vaccine injuries which should be conducted to carry out the VICP. The agenda items for the December 8, 2017, meeting will include, but are not limited to, review of petitions to add injuries to the vaccine injury table, and updates from DICP, Department of Justice (DOJ), National Vaccine Program Office (NVPO), Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http:// www.hrsa.gov/advisorycommittees/ childhoodvaccines/index.html) prior to the meeting. Agenda items are subject to change as priorities dictate. Members of the public will have the opportunity to provide comments. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to make oral comments or provide written comments to the ACCV should be sent to Annie Herzog using the address and phone number above by December 4, 2017. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Annie Herzog, using the address and phone number above at least 10 days prior to the meeting. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2017–24493 Filed 11–9–17; 8:45 am] BILLING CODE 4165–15–P E:\FR\FM\13NON1.SGM 13NON1

Agencies

[Federal Register Volume 82, Number 217 (Monday, November 13, 2017)]
[Notices]
[Page 52314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-24493]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act (FACA), 
notice is hereby given that a meeting is scheduled for the Advisory 
Commission on Childhood Vaccines (ACCV). This meeting will be open to 
the public. Information about the ACCV and the agenda for this meeting 
can be obtained by accessing the following Web site: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.

DATES: The meeting will be held on December 8, 2017, at 9:00 a.m. ET.

ADDRESSES: The address for the meeting is 5600 Fishers Lane, Rockville, 
MD, Conference Room 5N54. The public can join the meeting by:
    1. (In Person) Persons interested in attending the meeting in 
person are encouraged to submit a written notification to: Annie 
Herzog, Division of Injury Compensation Programs (DICP), Healthcare 
Systems Bureau (HSB), HRSA, Room 08N146B, 5600 Fishers Lane, Rockville, 
Maryland 20857 or email: aherzog@hrsa.gov. Since this meeting is to be 
held in a federal government building, attendees will need to go 
through a security check to enter the building and participate in the 
meeting. Written notification is encouraged so that a list of attendees 
can be provided to make entry through security quicker. Persons may 
attend in person without providing written notification, but their 
entry into the building may be delayed due to security checks and the 
requirement to be escorted to the meeting by a federal government 
employee. To request an escort to the meeting after entering the 
building, call Amber Johnson at (301) 443-0129.
    2. (Audio Portion) Calling the conference phone number 1-800-369-
1833 and providing the following information:
    Leader Name: Dr. Narayan Nair.
    Password: 6706374.
    3. (Visual Portion) Connecting to the ACCV Adobe Connect Pro 
Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work 
directly, and enter as a guest). Participants should call and connect 
15 minutes prior to the meeting in order for logistics to be set up. If 
you have never attended an Adobe Connect meeting, please test your 
connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by 
following URL: http://www.adobe.com/go/connectpro_overview.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the ACCV should contact Annie Herzog, Program Analyst, DICP, 
HRSA in one of three ways: (1) Send a request to the following address: 
Annie Herzog, Program Analyst, DICP, HSB, HRSA, 5600 Fishers Lane, 
08N146B, Rockville, Maryland 20857; (2) call (301) 443-6593; or (3) 
send an email to aherzog@hrsa.gov.
    The ACCV will meet on Friday, December 8, 2017, beginning at 9:00 
a.m. ET in the 5600 Fishers Lane Building, Conference Room 5N54, 
Rockville, Maryland 20857; however, meeting times and locations could 
change. For the latest information regarding meeting start time and 
location, please check the ACCV Web site: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.

SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of 
the Public Health Service Act (the Act) (42 U.S.C. 300aa-19), as 
enacted by Public Law (Pub. L.) 99-660, and as subsequently amended, 
and advises the Secretary of HHS (the Secretary) on issues related to 
implementation of the National Vaccine Injury Compensation Program 
(VICP).
    Other activities of the ACCV include: Recommending changes to the 
Vaccine Injury Table at its own initiative or as the result of the 
filing of a petition; advising the Secretary in implementing section 
2127 of the Act regarding the need for childhood vaccination products 
that result in fewer or no significant adverse reactions; surveying 
federal, state, and local programs and activities related to gathering 
information on injuries associated with the administration of childhood 
vaccines, including the adverse reaction reporting requirements of 
section 2125(b) of the Act; advising the Secretary on the methods of 
obtaining, compiling, publishing, and using credible data related to 
the frequency and severity of adverse reactions associated with 
childhood vaccines; consulting on the development or revision of 
Vaccine Information Statements; and recommending to the Director of the 
National Vaccine Program research related to vaccine injuries which 
should be conducted to carry out the VICP.
    The agenda items for the December 8, 2017, meeting will include, 
but are not limited to, review of petitions to add injuries to the 
vaccine injury table, and updates from DICP, Department of Justice 
(DOJ), National Vaccine Program Office (NVPO), Immunization Safety 
Office (Centers for Disease Control and Prevention), National Institute 
of Allergy and Infectious Diseases (National Institutes of Health), and 
Center for Biologics, Evaluation and Research (Food and Drug 
Administration). A draft agenda and additional meeting materials will 
be posted on the ACCV Web site (http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html) prior to the meeting. Agenda items are 
subject to change as priorities dictate.
    Members of the public will have the opportunity to provide 
comments. Oral comments will be honored in the order they are requested 
and may be limited as time allows. Requests to make oral comments or 
provide written comments to the ACCV should be sent to Annie Herzog 
using the address and phone number above by December 4, 2017. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify Annie Herzog, using the address and phone number above at least 
10 days prior to the meeting.

Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2017-24493 Filed 11-9-17; 8:45 am]
 BILLING CODE 4165-15-P